Are you Dr. Keogh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 121 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2085 Henry Tecklenburg Dr
Fl 2
Charleston, SC 29414Phone+1 843-577-6957Fax+1 843-723-3324
Summary
- Dr. George Keogh, MD is an oncologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, North Carolina, and New York. He is affiliated with Bon Secours St. Francis Hospital, Roper Hospital, and Roper St. Francis Mount Pleasant Hospital.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2001 - 2004
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
- SC State Medical License 2003 - 2025
- NY State Medical License 2000 - 2023
- NC State Medical License 2001 - 2004
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 106 citationsContinuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein
Journal of Clinical Oncology. 2020-09-10 - 23 citationsRandomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancerRichard D. Kim, Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii-Saab, Stacey M. Stein
European Journal of Cancer. 2020-05-01 - 135 citationsSafety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including...David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn
Journal of Thoracic Oncology. 2019-09-01
Professional Memberships
- Member